AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 587 businesses audited.
Medical Devices, Pharma & Biotech BS: Esperoct (Novo Nordisk) (esperoct.com)
This is a benchmark for low-BS pharmaceutical marketing where the ‘Flexibility’ signal is a direct, measurable consequence of the drug’s PEGylated molecular stability. Substance outweighs signal on every page.
To achieve a near-zero score, add a direct link to the published 2012-2020 real-world study cited in the Women’s section. Implement Person schema for the Community Liaisons to verify their roles. Consolidate the repeated storage temperature footnotes into a single high-visibility technical comparison table to reduce concept redundancy across the footer.
The site exhibits high information density with a substance-to-fluff ratio rarely seen in marketing. While headings like ‘Every experience matters’ are soft, the body text provides granular technical specifications such as storage durations (30 months at 36-46 °F) and six specific dosage strengths (500 IU to 4000 IU). The concept of ‘Flexibility’ is repeated 5+ times across pages, but it is consistently anchored to a specific technical deliverable: the 104 °F storage threshold.
Most sites "have schema," but AI still cannot understand what their pages represent. Run a Structured Data AI Audit to see what entity types your pages actually resolve into.
There is zero semantic drift between the homepage signal and sub-page substance. The H1 ‘Flexibility in hemophilia A’ on the homepage is directly supported by the ‘Flex Factor’ page, which defines flexibility through storage temperature and portability kit details. Unlike generic sites, the ‘Women in Hemophilia’ page actually addresses diagnostic barriers with real-world study data rather than just re-marketing the product.
Our Authority as a Service model transforms raw diagnostic data into high stakes results. Start your Clinical Strategic Diagnosis for 1 Euro to secure the strategic fixes required for growth.
Trust theatre is virtually non-existent because the site relies on verified regulatory documents rather than anonymous testimonials. While review_count is 0, the patient stories (Vaughn, Tammy, Craig) are identified by name and relationship to the product, including a transparent disclosure that one user works for Novo Nordisk. Performance claims regarding ‘fewer infusions’ are explicitly footnoted to comparative SHL data.
Proof density is extremely high. The site cites a ‘real-world study of data collected from 2012-2020,’ a ‘2021 survey of 49 HCPs,’ and MASAC guidelines. Verifiable technical storage data (36 °F to 104 °F) is provided for every stage of the product lifecycle.
For a high volume editorial domain example, open the Search Engine Journal Semantic HTML audit. View the SEJ Semantic HTML Audit to see how template drift and structural noise impact AI chunking.
The site uses some industry clichés like ‘on-the-go bleed protection’ and ‘day of adventure,’ but these are saved from being pure fluff by the unique storage claim. The value proposition—being the only EHL stable at 104 °F—is a distinct competitive differentiator that cannot be copy-pasted onto a competitor’s site. Template language is present in the ZIP code and Liaison sections but serves a functional purpose.
Authority is well-established through detailed JSON-LD MedicalWebPage schema and the backing of Novo Nordisk. A minor gap exists in the ‘Michael Norwood’ Liaison section, which lacks a direct professional profile link or Person schema, though this is common in pharma for privacy. Technical implementation is clean with zero hierarchy errors.
There is no disconnect between claims and evidence. The claim that the treatment ‘seamlessly fits into my schedule’ is backed by the quantifiable proof of ‘50% fewer infusions’ when compared to standard half-life products. The site correctly balances marketing ‘lifestyle’ benefits with rigorous FDA-mandated safety information.
Medical Devices, Pharma & Biotech BS: Esperoct (Novo Nordisk) (esperoct.com)
The content perfectly aligns with the Medical and Pharma category. It includes specific drug indications, non-proprietary names (antihemophilic factor (recombinant), glycopegylated-exei), and required safety warnings (5.1-5.4) characteristic of regulated pharmaceutical communications.
The access layer decides whether your content even enters the model's world. Review the Crawlability & Indexation Framework to see how AI visible content differs from what humans see in the browser.
“The score of 14 is driven primarily by the high Information Density (7) and the high uniqueness of the technical value proposition. The site avoided penalties in Semantic Coherence (0) due to perfect alignment between the flexibility promise and the technical proof of temperature stability. Minimal points were lost for generic value prop cliches and minor authority gaps regarding liaison profiles.”